Clinical Trial Update: Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating antithymocyte globulin (Thymoglobulin) in patients undergoing stem cell transplantation for multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Status: COMPLETED